What is the significance of mid-surgery tissue sample transport for advanced pathological testing as per ICMR trial

1. Mid-surgery tissue sample transport allows for real-time analysis of tumor characteristics, guiding surgeons on the extent of tissue resection required. 2. Enables precision medicine by providing critical information on tumor genetics and molecular profiles for personalized treatment. 3. Facilitates immediate identification of mutations or biomarkers that may impact treatment decisions, improving clinical outcomes. 4. Reduces delay in obtaining pathological results, expediting treatment planning and potentially leading to better patient prognosis. 5. Enhances research opportunities by collecting high-quality tissue samples for further studies and clinical trials, contributing to scientific advancements in cancer treatment.